Douglas H. Gebhard
- Epidemiology top 10%
- Virology top 2%
- Immunology top 10%
- Genetics top 10%
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Mary B. TompkinsRobert V. EnglishCalvin M. JohnsonW. A. F. TompkinsR L PageCarol B. GrindemVictor P. M. G. RuttenE. J. Ruitenberg
- Topics
- HIV Research and Treatment (5 papers)Immunotherapy and Immune Responses (4 papers)T-cell and B-cell Immunology (4 papers)
- Cited by
- VirologyImmunologySmall Animals
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Douglas H. Gebhard
21 papers receiving 904 citations
Peers
Comparison fields: 5 of 65
- Epidemiology 360
- Virology 312
- Immunology 308
- Genetics 195
- Public Health, Environmental and Occupational Health 170
Countries citing papers authored by Douglas H. Gebhard
This map shows the geographic impact of Douglas H. Gebhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas H. Gebhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas H. Gebhard more than expected).
Fields of papers citing papers by Douglas H. Gebhard
This network shows the impact of papers produced by Douglas H. Gebhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas H. Gebhard. The network helps show where Douglas H. Gebhard may publish in the future.
Co-authorship network of co-authors of Douglas H. Gebhard
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas H. Gebhard. A scholar is included among the top collaborators of Douglas H. Gebhard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas H. Gebhard. Douglas H. Gebhard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 53 | |
| 3 | 44 | |
| 4 | 37 | |
| 5 | 37 | |
| 6 | Immunophenotypic characterization of canine lymphoproliferative disorders. | 125 |
| 7 | 38 | |
| 8 | 111 | |
| 9 | 13 | |
| 10 | 7 | |
| 11 | 3 | |
| 12 | 176 | |
| 13 | 10 | |
| 14 | 9 | |
| 15 | 44 | |
| 16 | 93 | |
| 17 | 5 | |
| 18 | 55 | |
| 19 | 3 | |
| 20 | 50 |
About Douglas H. Gebhard
Douglas H. Gebhard is a scholar working on Virology, Immunology and Immunology and Allergy, having authored 21 papers that have together received 939 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), Immunotherapy and Immune Responses (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Virology (312 citations), Immunology (308 citations) and Small Animals (87 citations). Douglas H. Gebhard has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Mary B. Tompkins, Robert V. English, Calvin M. Johnson, W. A. F. Tompkins, R L Page, Carol B. Grindem, Victor P. M. G. Rutten, E. J. Ruitenberg, Elena Pinelli and Mary Jo Hamilton. Their work appears in journals such as The Journal of Immunology, Hepatology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.